JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4521 TCS PIM-1 1

Summary: Pim-1 kinase inhibitor,ATP-competitve

insoluble in H2O; insoluble in EtOH; ≥12.8 mg/mL
A4539 NFAT Inhibitor

Summary: NFAT inhibitor

insoluble in EtOH; ≥179.9 mg/mL
A4491 SGC-CBP30
2 Citation

Target: CREBBP|EP300

Summary: Inhibitor of CREBBP/EP300 bromodomain,potent

≥20.05 mg/mL
A8212 PR-619
4 Citation

Target: Deubiquitinating enzymes (DUBs)

Summary: Deubiquitylating enzymes (DBUs) inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
A8216 PP 2 (AG 1879)
2 Citation

Summary: Src-family kinases inhibitor

insoluble in H2O; ≥15.1 mg/mL
A8251 TAE684 (NVP-TAE684)

Summary: ALK inhibitor,potent and selective

≥61.4 mg/mL
A2197 Dacarbazine

Target: DNA Alkylating

Summary: Antineoplastic( malignant melanoma and sarcomas)

insoluble in EtOH; ≥0.54 mg/mL
A2476 Idarubicin HCl

Summary: Anthracycline and daunorubicin analog,topoisomerase inhibitor

≥26.7 mg/mL
A2949 Linifanib (ABT-869)

Target: VEGFR|PDGFR

Summary: VEGFR/PDGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
A2412 CP-724714

Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R

Summary: HER2 inhibitor,potent and selective

≥23.5 mg/mL